ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,412,610 | -7.4% | 94,427 | +3.9% | 0.00% | 0.0% |
| Q2 2023 | $2,605,291 | +44.3% | 90,840 | +20.6% | 0.00% | – |
| Q1 2023 | $1,805,924 | +39.0% | 75,341 | -1.6% | 0.00% | – |
| Q4 2022 | $1,298,830 | +15.9% | 76,582 | +1.3% | 0.00% | – |
| Q3 2022 | $1,121,000 | +3.4% | 75,596 | +9.7% | 0.00% | – |
| Q2 2022 | $1,084,000 | -48.3% | 68,885 | -11.4% | 0.00% | – |
| Q1 2022 | $2,097,000 | -27.4% | 77,770 | -0.3% | 0.00% | -100.0% |
| Q4 2021 | $2,888,000 | -21.3% | 78,038 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $3,669,000 | +53.2% | 76,777 | +8.5% | 0.00% | – |
| Q2 2021 | $2,395,000 | -21.4% | 70,769 | -4.1% | 0.00% | -100.0% |
| Q1 2021 | $3,047,000 | -13.5% | 73,785 | -9.1% | 0.00% | 0.0% |
| Q4 2020 | $3,522,000 | +30.7% | 81,213 | +29.3% | 0.00% | 0.0% |
| Q3 2020 | $2,694,000 | +9.0% | 62,789 | +18.7% | 0.00% | 0.0% |
| Q2 2020 | $2,472,000 | – | 52,892 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |